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Frameshifting results from two main mechanisms: genomic insertions or deletions (indels)
or programmed ribosomal frameshifting. Whereas indels can disrupt normal protein
function, programmed ribosomal frameshifting can result in dual-coding genes, each of
which can produce multiple functional products. Here, I summarize technical advances
that have made it possible to identify programmed ribosomal frameshifting events in a
systematic way. The results of these studies suggest that such frameshifting occurs in all
genomes, and I will discuss methods that could help characterize the resulting alternative
proteomes.
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INTRODUCTION
Frameshifting is a process whereby the ribosome is guided toward
a triplet nucleotide that is either shifted one nucleotide position
upstream (+1 frameshift) or one nucleotide position downstream
(−1 frameshift). Such frameshifting occurs in all known organ-
isms, from E. coli to mammals (Namy et al., 2004; Dinman,
2012a).
There are two main mechanisms that produce out of frame
peptides: changes in the genome sequence that result in insertions
or deletions (indels) and programmed ribosomal frameshift-
ing as a consequence of the ribosome either slipping back
one nucleotide (−1 frameshifting) or skipping one nucleotide
(+1 frameshifting) (Figure 1). Indels generally produce non-
functional proteins and are associated with either spontaneous
mutations across the genome or somatic genomic instability, for
instance, as a consequence of tumour progression. By contrast,
programmed ribosomal frameshifting can result in dual-coding
genes that produce alternative functional proteins, which form an
integral part of the organism’s physiology.
Programmed ribosomal frameshifting has been historically
associated with viruses and retrotransposons. Retroviruses
require frameshifting for replication and infection (Maia et al.,
1996; Brierley and Dos Ramos, 2006; Dulude et al., 2006). For
example, the HIV1 polyprotein gag-pol requires efficient −1
frameshifting for expression of the individual gag and pol gene
products. This form of frameshifting usually depends on a com-
bination of a “slippery sequence,” a spacer sequence of 1–15
nucleotides, and a stem-loop secondary RNA structure such
as a pseudoknot (Figure 1) (Namy et al., 2006). The slippery
sequence is generally of the type X XXY YYZ, where X denotes
any nucleotide, Y denotes A or U, and Z is A, U, or C. Pseudoknots
are secondary RNA substructures that contain two or more stem-
loop motifs with intercalated stems. The pseudoknot or stem-
loop structure in the mRNA is thought to result in pausing of
the ribosome, resulting in eventual frameshifting (Namy et al.,
2006). Structural evidence for this mechanism comes from the
crystal structure of the mouse mammary tumor virus (MMTV)
pseudoknot, which has an unpaired adenine that acts as a hinge
to mediate frameshifting (Chen et al., 1996). Generally, there is a
correlation between the mechanical strength of an mRNA pseu-
doknot and its frameshifting efficiency (Hansen et al., 2007): the
stronger the pseudoknot the higher the frameshifting efficiency,
although very strong pseudoknots can cause a road block that
limits translation downstream (Tholstrup et al., 2011).
Other examples of mammalian genes that utilize −1
frameshifting are the mouse embryonic carcinoma differentia-
tion regulated (EDR) gene and its human ortholog PEG10. A
slippery sequence of G GGA AAC, in combination with a pseudo-
knot, mediates highly efficient −1 frameshifting, similar to viral
frameshifting motifs (Clark et al., 2007). Recently, a programmed
ribosomal −1 frameshift has been identified in the adenoma-
tous polyposis coli (APC) mRNA in Caenorhabditis elegans that
is mediated by a slippery sequence A AAA AAA or A AAA AAC
(Baranov et al., 2011). The functional relevance of this frameshift
is uncertain.
Although the slippery sequence and pseudoknot are the most
common motifs for frameshifting identified thus far, there are
alternative mechanisms that may result in the production of
out-of-frame proteins. Alternative splicing may contribute to
frameshifting (Hiller et al., 2005), as can codon bias. For instance,
rare tRNA codons can favor −1 and +1 frameshifting (Gurvich
et al., 2005; Laine et al., 2008), and rare arginine codons prime
mitochondrial sequences for frameshifting (Temperley et al.,
2010). Moreover, CAG repeats are prone to frameshifting, which
results in poly-alanine proteins that may contribute to the patho-
genesis of neurodegenerative diseases (Toulouse et al., 2005). The
use of the peptidyltransferase inhibitor anisomycin reduces −1
frameshifting in these cases and reduces the toxicity associated
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FIGURE 1 | Principle of frameshifting– +1 vs. −1. Frameshifting can either result in skipping of one nucleotide in the mRNA resulting in +1 frameshifting or
slipping back one nucleotide resulting in −1 frameshifting.
with the expanded triplet repeats. Importantly, out-of-frame pro-
teins (compared to the standard ORFeome annotation) can also
result from alternative AUG or CUG start sites (Ingolia et al.,
2011), thereby considerably increasing the size of an alternative
“frameshifted” proteome. Main sources of out-of-frame peptides
and proteins are shown in Figure 2.
An interesting example of programmed ribosomal +1
frameshifting is that of the ornithine decarboxylase (ODC) gene
that produces the antizyme from frameshifting of the mRNA
sequence (Bekaert et al., 2008). ODC catalyzes the production
of polyamines, such as putrescine, spermidine, and spermine
from ornithine through decarboxylation. ODC activity is termi-
nated by the antizyme (Murakami et al., 1992)—providing an
elegant mechanism for shutting down the activity of an enzyme
by producing an out-of-frame antizyme from the same mRNA.
This frameshifting is tightly regulated and can be enhanced by
treatment of cells with polyamines (Nilsson et al., 1997). The
ODC antizyme mechanism is highly conserved throughout all
eukaryotes (Ivanov et al., 2000b). The frameshifting requires the
FIGURE 2 | Main sources for out-of-frame peptides. Regular expression
of this mRNA with translation initiating tRNAmet will result in expression of
peptide “AUG(0)” (red). Out-of-frame peptides could arise from alternative
out-of-frame CUG or AUG start sites resulting in translation of peptide
“CUG(−1)” (green). Alternatively, −1 or +1 frameshift signals within the
original reading frame could result in expression of out-of-frame peptides
“AUG(−1)” (blue) or “AUG(+1)” (yellow), respectively.
UGA stop codon and a 3′ stem loop that forms a RNA pseudo-
knot. These RNA hallmarks are still the standard way to identify
other +1 frameshifted proteins.
It has been proposed that frameshifting is a common mecha-
nism to increase protein-coding capacity of small genomes such
as those of viruses and mitochondria. In agreement with this
proposal, frameshifting is common in mitochondrial genes, and
genome size seems to correlate with the abundance of frameshift-
ing (Seligmann, 2010). In fact, some organisms display a high
complexity in frameshifting: In the dinoflagellate Perkinsus mari-
nus, the mitochondrial gene that encodes cytochrome c oxidase
subunit 1 can shift up to 10 times within the same mRNA
sequence in order to produce the correct gene product (Masuda
et al., 2010). Clearly, such complex frameshifting requires efficient
regulatory control.
REGULATION OF FRAMESHIFTING
There is increasing evidence that ribosomal frameshifting is a reg-
ulated event. Several enzymatic and non-enzymatic mechanisms
have been proposed that result in an enhancement of frameshift-
ing. For instance, the production of antizyme by+1 frameshifting
is enhanced by the end-products of ODC—spermine, putrescine,
and spermidine (Ivanov et al., 2000a). How polyamines regulate
+1 frameshifting is not well understood, but one hypothesis is
that polyamine binding to RNA may enable read-through of the
termination codon. Similar to polyamines, amino-glycosides such
as gentamicin allow read-through of stop-codons (Martin et al.,
1989; Malik et al., 2010).
It is not clear at present whether there are normal regula-
tor proteins that enhance frameshifting efficiencies. Because −1
frameshifting is essential for retroviral gene expression, it has been
proposed that chemical interference with frameshifting would
be a good anti-viral strategy. Recently, a genome-wide screen to
identify regulators of HIV-1 frameshifting has identified eRF1 as
an essential host gene required for −1 frameshifting (Kobayashi
et al., 2010), suggesting that eRF1 may be a good therapeutic tar-
get in AIDS (Brakier-Gingras et al., 2012). In addition, it has been
proposed that HIV frameshifting can be modulated by protein
kinase R, as well as by factors that modulate translation efficiency
such as rapamycin (Gendron et al., 2008).
Interestingly, annexin A2 (ANXA2) can bind the pseudoknot
structure of avian coronavirus infectious bronchitis virus (IBV)
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and reduce −1 frameshifting (Kwak et al., 2011). As a conse-
quence, ANXA2 has been suggested as a more general antiviral
regulator in eukaryotic cells. Other potential anti-viral agents
could either specifically bind to the frameshift signal (such as anti-
sense oligonucleotides, non-coding RNAs, or frameshift signal
binding compounds) or interfere with peptidyltransferase activity
(e.g., anisomycin or sparsomycin) or eEF2 activity (e.g., sordarin)
(Dinman, 2012b).
For certain diseases, however, it may be benefitial to enhance
frameshifting. For instance, in monogenetic diseases such as cys-
tic fibrosis or Duchenne’s muscular dystrophy, where frameshift
mutations result in premature translation termination, the delib-
erate induction of frameshifting may overcome the problem by
skipping the affected sites (Aurino and Nigro, 2006). It has
been noted that aminoglycosides such as gentamicin can enhance
frameshifting and stop codon read-through. Gentamicin-induced
read-through of stop codons has been evaluated as a treatment
option for Duchenne’s muscular dystrophy (Malik et al., 2010).
While the authors conclude from this phase I clinical trial that
gentamicin may not be a good treatment option, they note that
other read-through agents may have benefits. A phase I/II clin-
ical trial using a morpholino oligomer (AVI-4658) to correct a
frameshift mutation in the dystrophin gene has been completed
with the conclusion that AVI-4658 was well tolerated and had sig-
nificant benefit in patients with Duchenne’s muscular dystrophy
(Cirak et al., 2011).
DUAL CODING
Genome-wide analysis of the yeast genome (Jacobs et al.,
2007) and other genomes (Hammell et al., 1999) suggests
that frameshifting is more common than previously thought.
However, it has been proposed that frameshifting may predom-
inantly serve to modulate RNA levels rather than to produce
frameshifted proteins (Plant et al., 2004). Evolutionary stud-
ies argue that the generation of out-of-frame proteins has been
minimized by codon optimization that results in non-functional
small peptides rather than functional proteins (Bollenbach et al.,
2007). However, it is becoming increasingly recognized that
programmed ribosomal frameshifting can result in peptides or
proteins with physiological functions (Dinman, 2012a).
One question is whether frameshifting compromises the func-
tion of the original frame. It has been proposed that dual coding
limits the evolutionary flexibility of the underlying nucleotide
sequence (Firth and Brown, 2006; Rancurel et al., 2009). Thus,
one possibility may be that frameshifting occurs predominantly
in highly conserved, essential genes. However, it has been argued
that once a frameshift event is released from selective pres-
sure, as occurs in gene duplication, it can evolve to produce
a beneficial functional protein (Raes and Van de Peer, 2005).
Indeed, in some cases, novel genes seem to have emerged by
frameshifting of a pre-existing coding sequence (Ohno, 1984;
Ranz et al., 2003). Moreover, regulated frameshifting can allow
the same gene to produce alternative beneficial proteins. In fact,
evolutionary studies indicate a high abundance of frameshift
events in human and mouse genomes that may be linked to an
increased usage of the opal TGA stop codon (Okamura et al.,
2006).
It has been proposed that at least 1% of the human genome
consists of dual coding regions (Michel et al., 2012) and that
the number of out-of-frame peptides or proteins may be even
higher than that. Other studies have suggested that ∼10% of the
genome contains −1 frameshift signals (Belew et al., 2011). I
would argue that the number of frameshifted peptides or proteins
is somewhere in the range of 1–10% of the genome. This is a very
significant fraction of the genome, thus suggesting that out-of-
frame peptides are an inherent part of animal physiology and part
of evolutionary selection processes. Accordingly, it can be antici-
pated that dual coding is regulated and a common mechanism for
producing additional gene products. The main questions are:
1. What is the sequence or structural motif for dual coding?
2. What is the identity of all dual-coding genes and out-of-frame
proteins in the genome?
3. How is dual coding regulated?
To answer these questions, we need to look at commonly used
methods to identify frameshift events and out-of-frame peptides
and proteins.
METHODS TO IDENTIFY OUT-OF FRAME PEPTIDES
Soon after the discovery of programmed ribosomal frameshifting,
it was proposed that frameshifting may be a common mecha-
nism for dual decoding of genetic information (Dinman, 2012a).
The existence of an alternative genome has been postulated, but
it has remained difficult to identify. Most methods aim to identify
frameshifting events, but very few can determine which produce
functional out-of-frame gene products. A summary of meth-
ods to identify frameshifting events in mRNAs and out-of-frame
products is schematically shown in Figure 3.
Computational prediction has proven very useful. First, one
has to identify in mRNAs the requirements for a productive
frameshift peptide: One might argue that a slippery sequence
and a pseudoknot are a good predictor of frameshifting events,
but—as pointed out above—there are alternative mechanisms
that result in frameshifting (see also Figure 2). For identifica-
tion of the frameshifted products, I propose three hallmarks: first,
the presence of an initiation triplet (AUG or CUG) and a stop
codon in +1 or −1 frame; second, a stable peptide that follows
the 50-nt rule (Nagy andMaquat, 1998; Hillman et al., 2004); and
third, the validation that the peptide is endogenously expressed.
Validation can be done by low-throughput experimental meth-
ods, either using antibodies raised against the frameshifted pro-
tein or using genetic manipulations that ablate the frameshift
protein without disrupting the zero frame protein, if possible. To
identify frameshifting on a genome-wide scale, higher through-
put approaches can be applied, such as genomic, phenotypic, or
proteomic screening.
COMPUTATIONAL PREDICTION OF FRAMESHIFTING EVENTS
Several databases have been created to help predict frameshift
sequences in the genome. Such predictions are based on pri-
mary mRNA sequence stretches or on secondary hairpins or
pseudo-knots within themRNA sequence. For instance, Hammell
et al. searched the genome for slippery sequences and pseudoknot
www.frontiersin.org November 2012 | Volume 3 | Article 242 | 3
Ketteler On a frameshifted genome
FIGURE 3 | Methods to detect frameshifting events and out-of-frame
peptides. Computational methods (1) using databases that interrogate the
genome for −1 or +1 frameshift motifs can give information about
frameshifting events. Limitations of this approach are that only known
frameshift motifs are taken into account. Furthermore, this method does not
give any information whether predicted frameshift events occur in vivo or the
functional relevance of frameshifting events. Experimental methods (2) can
identify frameshift events that occur in vivo. Most commonly, an antibody
that is specific to the out-of-frame sequence of the frameshifted protein is
used to detect frameshifted proteins. Ribosome profiling methods such as
Ribo-Seq (3) can be used to detect out-of-frame peptides on a genomic scale.
cDNA screening and the use of tandem luciferase reporter constructs (4) can
be used to experimentally detect frameshift events. Limitations of this
approach are that overexpression may result in dysregulated expression and
differences in translation compared to endogenous expression levels.
Proteomic methods (5) using mass spectrometry are suitable to detect
endogenous out-of-frame peptides. However, the levels of frameshifted
proteins may be low and escape the detection limit. A combination of these
methods may provide most suitable to identify out-of-frame proteins on a
genome-wide scale. See text for details.
structures (Hammell et al., 1999). This approach identified over
200 putative programmed ribosomal frameshifting events. For
identification of pseudoknots and slippery sequences in the
genome databases such as RECODE, KnotInFrame, PRFdb, and
FSdB are very useful (Table 1).
RECODE provides information about programmed
frameshifting, read-through and bypassing, based on pub-
lished results in the literature (Baranov et al., 2001; Bekaert
et al., 2010). The database utilizes information from ∼1500
known frameshifted gene products. A majority of the data
on frameshifting comes from two frameshifted proteins, RF2
and antizyme, and is constantly updated using the respective
prediction tools [ARFA (Bekaert et al., 2006) and OAF (Bekaert
et al., 2008), respectively]. PseudoViewer is used for visualization
of pseudoknot structures. (http://recode.ucc.ie)
KnotInFrame is a program for predicting sites of −1
frameshifting based on the formation of RNApseudoknots (Theis
et al., 2008). The authors have developed a specialized RNA-
folding program called pknotsRG-fs that compares the minimal
free energy of an enforced pseudoknot structure to that of a freely
folded structure such as that given by RNAfold. The spacer region
after the common slippery sequence X XXY YYZ is between 1 and
12 nt long. (http://bibiserv.techfak.uni-bielefeld.de/knotinframe)
PRFdb (http://prfdb/umd.edu/) is limited to −1 frameshift-
ing in eukaryotes only. Again, the prediction if based on the
presence of a heptameric slippery sequence in combination with
a pseudoknot (Jacobs et al., 2007). The slippery sequence is
modeled with a 1–8 nt spacer, and the pseudoknot is identi-
fied using RNAMotif. The pseudoknot is then further confirmed
with other secondary RNA-structure-prediction tools, including
Pknots (Rivas and Eddy, 1999), Nupack (Dirks and Pierce, 2004),
and HotKnots (Ren et al., 2005).
The Frameshift Signal Database (FSDB) is a compilation of
all known frameshift motifs, plus some reported (predicted)
frameshift sequences (Moon et al., 2007). Based on common-
alities between these sequences, the associated FSFinder allows
mining of the genome for potential frameshift sequences. (http://
wilab.inha.ac.kr/fsdb) At present, the database contains a total
of 63 experimental and 190 predicted sequences from viruses,
prokaryotes and eukaryotes. FSFinder uses a combination of
slippery sequences and pseudoknot or stem-loop prediction. The
heptameric slippery sequences for +1 and −1 frameshifting are
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Table 1 | Databases for prediction of −1 and +1 frameshifting.
Database Prediction motif Pseudoknot References
RECODE Known frameshift
sequences (∼1500
genes)
Pseudoviewer,
ARFA, OAZ
http://recode.ucc.ie/
KnotInFrame X XXY YYZ
Spacer 1–12 nt
pKnotsRG-fs http://bibiserv.techfak.
uni-bielefeld.de/
knotinframe/
PRFdb X XXY YYZ
Spacer 1–8 nt
RNAmotif,
pKnots, Nupack,
Hotknots
http://prfdb.umd.edu/
FSDB See Table 2; 63
known frameshift
sequences and 190
predicted sequences
FSFinder http://wilab.inha.ac.kr/
fsdb/
KnotInFrame and PRFdb rely entirely on computational prediction of a combina-
tion of a slippery sequence, a spacer and pseudoknot or stem-loop structure,
while RECODE and FSDB compile known frameshift sequences in order to
predict similar motifs in other genes.
Table 2 | Slippery sequences used by FSDB for prediction of
out-of-frame peptides.
−1 Frameshift +1 Frameshift
AAAAAA C/G/U AAA UAA A
AAAAG CCC U
AAAUUU A/C/G/U CCC UGA
CCCAAA A/C/G CUU AGG
CCCUUU A CUU UAA C
CGAAAG CUU UGA C
GGAUUU A/U GCG A
GGGAAA A/C/G/U UCC UGA
GGGCCC C/U UUU UGA
GGGGAA C
GGGUUU A/C/U
GUUAAA C
UUUAAA A/C/U
UUUUUU A/C/G
Sequences predictive of −1 frameshifting include classical heptameric X XXY
YYZ sequences and also include shorter sequence stretches. Sequences predic-
tive of +1 frameshifting often contain an in-frame stop codon, thus resulting in
stop codon by-passing such as in the case of ODC.
listed in Table 2. It is noteworthy that FSDB includes deviations
from the standard X XXY YYZ slippery sequence for prediction of
−1 frameshifting, whereas +1 frameshift sequences often contain
stop codons.
Although most prediction databases use similar principles
(slippery sequence plus pseudoknot), they differ in prediction
of frameshifting events. This may be due to variable thresholds
applied or different RNA folding algorithms. In order to identify
expressed proteins, one has to consider the length of the pre-
dicted out-of-frame protein. Most frameshifted proteins initiated
by predicted slippery sites will terminate within 5–10 codons,
thus producing truncated or non-functional peptides or proteins.
Alternative approaches that take out-of-frame protein length
into account might be beneficial. For instance, MLOGD (http://
guinevere.otago.ac.nz/aef/MLOGD/) is a program for detection
of overlapping coding sequences based on sequence alignments
and analysis of mutation patterns (Firth and Brown, 2006).
The limitations of this approach are that less conserved coding
sequences will not be identified, and -2 frame overlaps can be
identified as false positives.
In some organisms, including mammals, codon usage has
evolved to minimize frameshifting. Thus, it can be expected that
certain codons may favour frameshifting. FSCAN is a program to
identify +1 frameshift sequences based on codon usage in E. coli
(Liao et al., 2009). FScan searches 16 nt sequences and calcu-
lates a score for aa-tRNA competition between the zero and +1
frame. Accordingly, a stop codon, or a rare codon in the zero
frame can be a predictor of+1 frameshifting. Shah et al. suggested
that selective pressure would lead to an under-representation of
frameshift sites in protein-coding sequences relative to an organ-
ism’s codon bias (Shah et al., 2002). They predicted the sequences
CUU AGG C and CUU AGU U, which mediate +1 frameshifting
of ABP140 and EST3, respectively, to be highly under-represented
and predictive for frameshifting in S. cerevisiae.
Once frameshifting events have been identified, it is impor-
tant to characterize the gene products. One could apply the
filters mentioned above, such as the 50-nt rule, although it is
quite possible that short peptides are stable and endogenously
expressed (Kondo et al., 2010; Ingolia et al., 2011). Ultimately,
all predictions of frameshifted peptides need to be validated with
experimental methods.
LOW-THROUGHPUT EXPERIMENTALMETHODS
Experimental methods include generation of frameshift-specific
antibodies, reporter constructs, biophysical methods, and single
molecule measurements. The most commonly used frameshift
reporter is a tandem luciferase construct where the two luciferases
with different substrate specificities are separated by a stretch
of nucleotides of a length that shifts the downstream luciferase
either one nucleotide up or down (Grentzmann et al., 1998). The
downstream luciferase will be expressed only if the nucleotide
stretch can mediate frameshifting, while the upstream luciferase
serves as an expression control. Alternative reporter genes include
the use of fluorescent proteins (Cardno et al., 2009), although
the dynamic range of luciferases is generally much higher.
This reporter can be used experimentally to confirm predicted
frameshift events.
One hypothesis is that the −1 frameshifting efficiency cor-
relates with the mechanical force required for pulling the RNA
pseudoknot apart. With biophysical single-molecule methods
that measure these forces using optical tweezers, Hansen et al.
have confirmed that unfolding of a IBV-based pseudoknot
required ∼500 kJ/mol, compared to the theoretically determined
292 kJ/mol (Hansen et al., 2007). Chen et al. have determined that
a 100% confidence in −1 frameshifting is reached by an unfold-
ing force of ∼57 pN (Chen et al., 2009). Such single-molecule
biophysical approaches may help to identify potential frameshift
sequences, but as they require immobilization of the RNA, they
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will be technically challenging to implement on a genome-wide
scale.
An alternative is the use of single molecule Foerster Resonance
Energy Transfer (smFRET) (Aitken and Puglisi, 2010). FRET
is a useful technique to measure proximity of biomolecules. A
donor fluorophore attached to a molecule can transfer pho-
tons to an acceptor fluorophore on a different molecule when
both molecules are close together (generally less than 10 nm).
Aitken and Puglisi have used this technique to label individ-
ual tRNA molecules with donor and acceptor dyes that result
in energy transfer when in close proximity and correct orienta-
tion. This technique enables to monitor relative tRNA positions
and movement of tRNAs on ribosomes at a millisecond scale.
It has been used to identify ribosomal translocation events on
fluorescent ribosomes on immobilized RNA sequences and pre-
dicted the slipperiness of various RNA sequences. Again, this
will be technically difficult to implement on a genome-wide
scale.
All of the above methods will record mostly frameshifting
events, but they will not validate the expression of an out-of-
frame protein. It is worth noting that frameshifting will most
likely result in chimeric sequences composed of a stretch of zero
frame peptides linked to out-of-frame peptides, which can be a
small or large part of the overall protein, depending on where
the frameshift site is. Alternatively, frameshifting could lead to
truncation of the original protein, where a very small fraction—
if any—of the overall protein is out-of-frame (Figure 4). Those
proteins that have a sufficient predicted length could then be
validated by raising specific antibodies against that sequence.
In order to raise an antibody, one has to know the precise
FIGURE 4 | Protein composition as a consequence of frameshifting.
The original zero frame is shown in gray, whereas out-of-frame sequences
are shown in red or blue colour. A frameshifting event is marked by the
arrow. Frameshifting can result in chimeric peptides composed of the
original frame and out-of-frame sequences that can form a small or larger
part of the overall protein, depending on where the frameshift event takes
place. It is also possible that more than one frameshifting event takes place
within the same mRNA, thus resulting in mosaic hybrid peptide sequences.
(A, Original frame; B, early frameshift with extended ORF; C, early
frameshift with truncation; D, late frameshift with extended ORF; E, two
frameshift events that switch back to the zero frame; and F, two frameshift
events that produce a chimeric sequence of three different frames.)
sequence of the frameshifted protein. Therefore, this approach
is useful for confirming a known out-of-frame protein, but it is
not amenable to large-scale genome-wide screening. In addition,
the detection of an endogenously expressed out-of-frame pro-
tein does not necessarily indicate a functional relevance for this
protein.
In order to validate a physiological role for the frameshifted
gene product, the best method is to genetically ablate the expres-
sion of the frameshifted protein while preserving the in-frame
sequence. This can be accomplished by gene targeting with a
gene sequence that harbours multiple wobble base pair muta-
tions or mutating the frameshift motif, thus altering the RNA
sequence but not the in-frame protein sequence. This is techni-
cally challenging and may not always be feasible. For instance, an
OAZ3 knockout mouse model has been generated, where both
the zero frame and the+1 frame has been deleted (Tokuhiro et al.,
2009). Tomy knowledge, no specific gene targeting of a frameshift
protein has been done so far.
GENOMIC METHODS
Genomic methods such as RNA sequencing (RNA-seq) have
emerged as powerful tools to profile RNA content in cells.
RNA-seq is based on high-throughput sequencing of a cDNA
library generated from cellular RNA. In its standard form, RNA-
seq enables the identification of indels, but will fail to identify
post-transcriptional phenotypes and will therefore fail to iden-
tify programmed ribosomal frameshifting or dual coded genes.
Nevertheless, ribosome profiling methods such as Ribo-seq have
been developed that allow the identification of active translation,
based on sequencing of cDNA libraries generated from ribosome-
protected fragments (Ingolia et al., 2009). In this case, mRNA
bound to ribosomes is first cross-linked and then isolated using,
e.g., sucrose gradient density centrifugation. Next, a nuclease
digestion step results in removal of mRNA sequence that is not
bound (“protected”) to ribosomes. The protected RNA bound to
ribosomes is then reverse transcribed into cDNA and sequenced.
Therefore, the precise position of a ribosome can be matched
to the site of active translation. An adaptation of this method
using the drug harringtonine to cause ribosome accumulation
at initiation codons has allowed the identification of transla-
tion start sites and confirmed that many proteins are initiated at
non-AUG or alternative AUG sites (Ingolia et al., 2011). In this
study, 44% of detected AUG start sites were unannotated, and
a large fraction of these encoded out-of-frame peptides. Further
uses of ribosome profiling have confirmed that the identifica-
tion of frameshifts is possible using genomic technologies (Michel
et al., 2012). Although this approach is unbiased in the sense that
it does not pre-filter genetic regions, one problem is the non-
uniformity of ribosome-protected fragment reads. For instance,
the preparation of cDNA libraries generated from ribosome-
protected fragments can result in over- or under-representation
of sequence reads. This can be overcome by a computational
approach that measures the cumulative subcodon proportion
difference of ribosome-protected fragments relative to local sub-
codon positions. The authors have therefore combined experi-
mental data from Ribo-Seq with a computational approach in
order to identify novel frameshifted protein sequences. Using
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this approach, several new frameshifted protein sequences were
identified, most of which were dual-encoded. The authors esti-
mate that more than 1% of the genome may consist of dual-
coding regions, and this is likely an underestimation. Further
improvements to the method, including deeper sequencing to
get better coverage of ribosome-protected fragments, will help to
identify these genes.
PHENOTYPIC SCREENING
Most genome-wide screening approaches such as RNAi-based
knockdown methods will fail to identify dual-coding regions,
as both gene products will be deleted. Further, most commonly
used cDNA libraries such as the ORFeome are designed to avoid
expression of frameshifted peptides—for instance, by deletion
of the 5′ and 3′-UTR. It may, however, be possible that cer-
tain phenotypes in cDNA screening are exerted by out-of-frame
proteins. In order to fish for phenotypic effects exerted by such
peptides, cDNA libraries can be designed in a way that genomic
fragments are inserted downstream of an AUG start codon in
+1 or −1 frame so that all genomic fragments are deliberately
frameshifted. A subsequent functional phenotypic screen can
then identify phenotypes associated with expression of such delib-
erate frameshift fragments. However, there are limitations in such
an approach, e.g., where to place the frameshift. Also, deliberately
expressed out-of-frame proteins may have little physiological
relevance.
An alternative may be to use agents such as gentamicin that
enhance programmed frameshifting. In that case, cells expressing
a cDNA library would be treated with a frameshift inducer, and
the occurrence of differential phenotypes plus/minus frameshift
inducer would be recorded. It is imperative that cDNA libraries
with 3′-UTR regions are used in such an approach to facil-
itate the out-of-frame peptide expression after stop codon
read-through.
A similar approach can be used to identify endogenous regu-
lators of frameshifting. One could use the dual luciferase reporter
construct (Grentzmann et al., 1998) with a known frameshift
motif and screen siRNA or cDNA libraries to identify genes that
enhance or inhibit the frameshifting efficiency of this reporter.
The existence of non-coding RNAs that modulate frameshift-
ing suggests that frameshifting is regulated by endogenous gene
products.
The dual luciferase reporter mentioned above can also be
used to probe the sequence space for optimal frameshifting
motifs (Rakauskaite et al., 2011). Recently, an adaptation of
this approach has been developed using fluorophores that are
amenable to high-throughput screening applications (Cardno
et al., 2009). An in vivo adaptation for yeast cells has been pro-
posed for use in high-throughput screening experiments (Harger
and Dinman, 2003). For instance, a random nucleotide sequence
can be inserted between the in-frame and the out-of-frame
luciferase to determine which sequence will result in high levels
of out-of-frame expression. Themain advantages of such a system
are the broad linear range of the assay, the internal mRNA expres-
sion control (luciferase 1), the possibility to normalize relative
frameshift expression, and the ease of use. One problem with the
approach is that the secondary structure is affected by the length
of the sequence inserted in the dual luciferase reporter. Thus, the
context of the frameshift motifs needs to be taken into account.
Further, the high number of potential nucleotide combinations
may outweigh the capacity of even highly automated processes.
Even though this will identify putative sequences with high poten-
tial for frameshifting, it is still not clear whether the out-of-frame
peptides or proteins are stable and functional. Their presence
in open reading frames may hint that a frameshift is buried
within the gene. Subsequent low-throughput experimental meth-
ods (see above) need to be designed to confirm expression of the
frameshifted protein.
PROTEOMICS
Proteomic approaches have enabled the identification of
expressed peptides under physiological conditions. In mass spec-
trometry (MS), peptides of endogenous proteins are first detected
as a mass per ion. In the most common approach, recorded
masses are matched to all potential masses in the respec-
tive database by search algorithms like SEQUEST, MASCOT,
Andromeda, or PEAKS. In a next step, sequence information
generated in tandem MS (MS/MS) experiments is employed
to identify potential hits within the shortlisted peptide vari-
ants. Commonly searched databases by MASCOT are SwissProt,
NCBInr, and EMBL EST. These databases integrate cDNA and
EST sequences and generally do not contain out-of-frame pep-
tides. However, as MS database search algorithms compute the
entire sequence space of potential peptide matches to identify
peptides within analyzed samples, it is in principle possible to
identify out-of-frame peptides.
An interesting approach for the identification of frame-shift
peptides is de novo sequence analysis by MS. This is based solely
on the analysis of MS and MS/MS spectra, without amino acid
sequence information from databases. However, identification
rates are typically lower than in classical database-based pro-
teomics experiments.
A major difficulty is to assign frame-shifted peptides to a par-
ticular gene. Decoding of the underlying nucleotide sequence is
sometimes problematic, as, for instance, isoleucine and leucine
have the same exact mass. In some cases, the identified peptides
do not match the database for various reasons, including errors
in gene/protein annotation and post-translational modifications
in the peptides that are not accounted for. Usually, unmatched
peptides are not reported in publications and are disregarded
from further analysis. It is possible that some of these unmatched
peptides correspond to an alternative reading frame. In order
to match these peptides, one would need to generate a database
derived from the +1/−1 frames of the ORFeome, similar to what
Okamura et al. have done (Okamura et al., 2006), and make
these accessible to the proteomic community. One problem is the
“breakpoint” of frameshifting, which would generate a peptide
that is partially composed of the original frame and partially of
the frameshifted peptide (see Figure 4). Another problem in this
approach may be the paucity of frameshifted peptides, as they
are commonly expressed at lower levels (see above) and may not
be easily detectable by MS approaches. However, MS is probably
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the most powerful method to identify out-of-frame peptides to
confirm endogenous expression.
An alternative is to study peptides presented by cell-surface,
class I MHC proteins. They present peptides derived from
intracellular proteins to enable immune tolerance and immune
surveillance. MHC-presented out-of-frame peptides were discov-
ered in the early 1990’s (Shastri et al., 1995) and have enabled
the unbiased identification of endogenous frameshifting in mam-
malian cells long before the technical advances of MS. However, it
is technically challenging to use this approach as a systematic tool
for the identification of genomic out-of-frame peptides.
OUTLOOK
In which cellular processes should we expect to see a high abun-
dance of frameshifted proteins? In principle, such proteins might
be involved in any cellular process, but may be correlated with
certain cellular pathways. For instance, amino acid starvation
can induce frameshifting in bacteria (Barak et al., 1996). One
hypothesis is that this is due to a short supply of amino-acylated
tRNA as a consequence of amino acid limitations. This is sup-
ported by the observation that antizyme expression (the +1
frame) is maintained under conditions of amino acid starva-
tion, while expression of ODC (the 0 frame) is reduced in rat
intestinal epithelial cells (Ray et al., 2012). Moreover, treatment
with mTOR inhibitors such as rapamycin also reduce 0 frame
expression while maintaining antizyme expression. One could
hypothesize that reduced fidelity in translation may enhance
frameshifting. On the other hand, both translation inhibition and
amino acid starvation are conditions that increase autophagy in
eukaryotic cells, raising the possibility that the production of out-
of-frame proteins may be functionally coupled to the regulation
of autophagy.
CONCLUSION
There is increasing evidence for an alternative genome/proteome
in both prokaryotes and eukaryotes, reflecting programmed ribo-
somal frameshifting. It is likely that a combination of compu-
tational, experimental, genomic, and proteomic methods will
be needed to determine the entire frameshifted proteome, as
required to understand fully gene expression in any organism.
We need to identify the frameshift motifs that enable frameshift-
ing, as well as all the genes that produce out-of-frame peptides.
Finally, as a low level of frameshifting can be considered “biolog-
ical noise,” we need to determine the physiological relevance of
these frameshifted proteins.
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